From: Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease
Cells | Disease | Function | Research types | Ref |
---|---|---|---|---|
BMSCs | CHD | Modulate immune response | Animal | [70] |
PAD | Perfusion recovery Running capability increased | Animal | [71] | |
ADSCs | PAD | Muscle function improved Perfusion increased Inflammatory infiltrate reduced | Animal | [72] |
CAD | Angiogenesis Neurogenesis | Animal | [73] | |
HUCMSCs | CHD | Improve cardiac systolic function Reduce cardiac fibrosis Suppress cell apoptosis Promote cell proliferation Angiogenesis | Animal | [74] |
PAD | Promote angiogenesis Improve blood perfusion | Animal | [27] | |
CAD | Suppress inflammatory responses and neuronal apoptosis | Animal | [75] | |
CAD | Decrease brain injury loss Reduce neurological function deficits Increase VEGF expression | Animal | [76] | |
EPCs | CAD | Angiogenesis | Animal | [77] |
PAD | Angiogenesis | Animal | [78] | |
iPSCs | CHD | Improve cardiac function | Animal | [79] |
CHD | Inhibit ventricular remodeling | Animal | [80] | |
CHD | Improve cardiac function | Animal |